Mitani K, Graham F L, Caskey C T, Kochanek S
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3854-8. doi: 10.1073/pnas.92.9.3854.
Adenoviral vectors are widely used as highly efficient gene transfer vehicles in a variety of biological research strategies including human gene therapy. One of the limitations of the currently available adenoviral vector system is the presence of the majority of the viral genome in the vector, resulting in leaky expression of viral genes particularly at high multiplicity of infection and limited cloning capacity of exogenous sequences. As a first step to overcome this problem, we attempted to rescue a defective human adenovirus serotype 5 DNA, which had an essential region of the viral genome (L1, L2, VAI + II, pTP) deleted and replaced with an indicator gene. In the presence of wild-type adenovirus as a helper, this DNA was packaged and propagated as transducing viral particles. After several rounds of amplification, the titer of the recombinant virus reached at least 4 x 10(6) transducing particles per ml. The recombinant virus could be partially purified from the helper virus by CsCl equilibrium density-gradient centrifugation. The structure of the recombinant virus around the marker gene remained intact after serial propagation, while the pBR sequence inserted in the E1 region was deleted from the recombinant virus. Our results suggest that it should be possible to develop a helper-dependent adenoviral vector, which does not encode any viral proteins, as an alternative to the currently available adenoviral vector systems.
腺病毒载体作为高效的基因传递载体,在包括人类基因治疗在内的各种生物学研究策略中被广泛应用。目前可用的腺病毒载体系统的局限性之一是载体中存在大部分病毒基因组,这导致病毒基因的渗漏表达,尤其是在高感染复数时,并且外源序列的克隆能力有限。作为克服这一问题的第一步,我们试图拯救一种有缺陷的人类5型腺病毒DNA,该病毒基因组的一个必需区域(L1、L2、VAI + II、pTP)被删除并用一个指示基因取代。在野生型腺病毒作为辅助病毒存在的情况下,这种DNA被包装并作为转导病毒颗粒进行繁殖。经过几轮扩增后,重组病毒的滴度达到至少每毫升4×10(6)个转导颗粒。重组病毒可以通过CsCl平衡密度梯度离心从辅助病毒中部分纯化出来。经过连续传代后,重组病毒围绕标记基因的结构保持完整,而插入E1区域的pBR序列从重组病毒中删除。我们的结果表明,开发一种不编码任何病毒蛋白的辅助依赖型腺病毒载体作为目前可用的腺病毒载体系统的替代物应该是可行的。